Home › Chronic Lymphocytic Leukemia › Missouri › St. Louis
Chronic Lymphocytic Leukemia clinical trials in St. Louis, MO
8 studies for Chronic Lymphocytic Leukemia are looking for participants at sites in and around St. Louis (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Study to Investigate the Safety of Novel Dose Ramp-up Schedule(s) When Initiating Sonrotoclax in Participants Treated for Blood Cancers.
RecruitingPhase 1/2
- Washington University School of Medicine, St Louis
A Study to Evaluate the Safety and Efficacy of Tacabrutideg (BGB-16673) Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
RecruitingPhase 3
- Washington University School of Medicine, St Louis
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
RecruitingPhase 3
- Mercy Hospital South, St Louis
- Missouri Baptist Medical Center, St Louis
- Mercy Hospital Saint Louis, St Louis
- and 1 more
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RecruitingObservational studyHealthy volunteers welcome
- Mercy Infusion Center - Chippewa, St Louis
- Mercy Hospital South, St Louis
- Missouri Baptist Medical Center, St Louis
- and 4 more
Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL
RecruitingPhase 3
- Washington University School of Medicine, St Louis
- Siteman Cancer Center-South County, St Louis
- Missouri Baptist Medical Center, St Louis
- and 5 more
A Phase 1 Study of UB-VV111 With and Without Rapamycin in Relapsed/Refractory CD19+ B-cell Malignancies
RecruitingPhase 1
- Washington University School of Medicine/Siteman Cancer Center, St Louis
64Cu-LLP2A for Imaging Hematologic Malignancies
RecruitingEarly phase 1Healthy volunteers welcome
- Washington University School of Medicine, St Louis
A Safety and Efficacy Study Evaluating CTX112 in Subjects With Relapsed or Refractory B-Cell Malignancies
RecruitingPhase 1/2
- Washington University, St Louis
Chronic Lymphocytic Leukemia trials in other cities
- Boston, MA32 studies
- Columbus, OH29 studies
- Durham, NC27 studies
- Washington, DC22 studies
- Seattle, WA21 studies
- Rochester, MN19 studies
- New York City, NY18 studies
- Houston, TX17 studies
- Baldwin Park, CA16 studies
- Milwaukee, WI14 studies
- Cincinnati, OH14 studies
- Chicago, IL14 studies
Other studies in St. Louis
- Non-Small Cell Lung Cancer71 studies
- Breast Cancer65 studies
- Metastatic Cancer53 studies
- Colorectal Cancer49 studies
- Prostate Cancer47 studies
- Cancer (all types)46 studies
- Lung Cancer39 studies
- Ovarian Cancer36 studies
- Pancreatic Cancer33 studies
- Endometrial Cancer29 studies
- Head and Neck Squamous Cell Carcinoma28 studies
- Heart Failure26 studies
From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.